Subcutaneous Injection Market Report 2025 (Global Edition)

Global Subcutaneous Injection Market Report 2024 Market Size Split by Product Type (Syringes, Injection Pens, Infusion Pumps), by Drug Type (Biologics, Small Molecules), by Application (Diabetes, Rheu...

Subcutaneous Injection Market Report Description

We have various report editions of Subcutaneous Injection Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Subcutaneous Injection Market Insights Video

Competitive Landscape of the Subcutaneous Injection Market

The competitive landscape of the subcutaneous injection market is characterized by key players focusing on innovation, product differentiation, and strategic collaborations. Major companies invest in advanced technologies, such as smart injection devices and digital health solutions, to enhance patient experience and adherence. Partnerships with healthcare providers and research institutions further bolster product development and market reach. Additionally, emerging players are entering the market with cost-effective solutions, intensifying competition and driving continuous improvements in device design and functionality to meet evolving patient needs.

In Jan 2023, Alcyone Therapeutics and Biogen Inc. entered into a collaboration and license agreement to an implantable medical device, Alcyone’s ThecaFlex DRx™ System intended for subcutaneous delivery of antisense oligonucleotide (ASO) therapies into the intrathecal space. (Source: https://investors.biogen.com/news-releases/news-release-details/biogen-and-alcyone-therapeutics-announce-license-and) In December 2023, a global provider of drug containment and delivery solutions to the pharmaceutical, life sciences, and biotechnology industries, Stevanato Group, S.p.A launched its On-Body Delivery System (OBDS), Vertiva intended to be allowed to switch between bolus and basal and to be suitable for a wide range of subcutaneous therapies. (Source: https://www.stevanatogroup.com/en/news-events/press-releases/stevanato-group-presents-vertiva/) In February 2024, Novo Nordisk A/S partnered with HemoCue to enhance point-of-care diagnostic testing for children with type 1 diabetes in low- & middle-income nations. (Source: https://www.hemocue.com/en/press-release/)

Top Companies Market Share in Subcutaneous Injection Industry: (In no particular order of Rank)

• AbbVie Inc.
• Amgen Inc.
• Bristol-Myers Squibb Company
• Novo Nordisk A/S
• Sanofi S.A.
• Eli Lilly and Company
• Roche Holding AG
• Johnson & Johnson
• Merck & Co.
• Inc.
• Gilead Sciences
• Inc.
• Pfizer Inc.
• Biogen Inc.
• Sandoz (Novartis AG)
• F. Hoffmann-La Roche Ltd.
• Medtronic plc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Subcutaneous Injection Market

Which Region Dominates the Subcutaneous Injection Market in 2024?

According to Cognitive Market Research, North America is poised to dominate the subcutaneous injection market in 2024, driven by a robust healthcare infrastructure, high prevalence of chronic diseases, and significant investments in healthcare technologies. The region benefits from a strong presence of major pharmaceutical and biotechnology companies, which focus on developing advanced injection devices and biologic therapies. Furthermore, increasing patient awareness and the growing preference for self-administration options contribute to market expansion. Supportive reimbursement policies and a proactive approach toward chronic disease management further enhance the appeal of subcutaneous injections within North American healthcare settings.

Which Region is Expanding at the Fastest CAGR?

The Asia-Pacific region is expanding at the fastest CAGR in the subcutaneous injection market, driven by increasing healthcare investments and a rising burden of chronic diseases. Growing urbanization and improved healthcare access contribute to the adoption of self-administered injection devices. The expanding pharmaceutical sector, characterized by the introduction of innovative biologics and personalized medicine, further fuels market growth. Additionally, increasing awareness of advanced treatment options and a shift toward home healthcare solutions are propelling demand. Governments in the region are also implementing initiatives to enhance healthcare infrastructure, supporting the expansion of the subcutaneous injection market.

The current report Scope analyzes Subcutaneous Injection Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Subcutaneous Injection

According to Cognitive Market Research, the global Subcutaneous Injection market size was estimated at USD XX Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Subcutaneous Injection market with a market size of USD XX million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Advanced healthcare infrastructure and high chronic disease prevalence drive the U.S. market growth.
• The Canada Subcutaneous Injection market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Canada's publicly funded healthcare system enhances accessibility and chronic disease management.
• The Mexico Subcutaneous Injection market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD XX million in 2024.

Europe Subcutaneous Injection

According to Cognitive Market Research, the global Subcutaneous Injection market size was estimated at USD XX Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

• The United Kingdom Subcutaneous Injection market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. Strong healthcare policies and a trend toward patient self-administration boost the UK market.
• The France Subcutaneous Injection market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD XX million in 2024.
• According to Cognitive Market Research, the German Subcutaneous Injection market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. A robust pharmaceutical industry and patient awareness fuel Germany's subcutaneous injection market.
• The Italy Subcutaneous Injection market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD XX million in 2024.
• The Russia Subcutaneous Injection market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD XX million in 2024.
• The Spain Subcutaneous Injection market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD XX million in 2024
• The Luxembourg Subcutaneous Injection market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD XX million in 2024.
• The Portugal Subcutaneous Injection market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD XX million in 2024.
• The Greece Subcutaneous Injection market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of Europe's Subcutaneous Injection market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD XX million in 2024.

Asia Pacific Subcutaneous Injection

According to Cognitive Market Research, the global Subcutaneous Injection market size was estimated at USD XX Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Subcutaneous Injection market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. Rapid urbanization and expanding healthcare access increase demand for chronic disease solutions in China.
• The Japan Subcutaneous Injection market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD XX million in 2024.
• The India Subcutaneous Injection market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. Rising incomes and healthcare investments support market growth in India.
• The South Korean Subcutaneous Injection market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD XX million in 2024.
• The Australian Subcutaneous Injection market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD XX million in 2024.
• The South East Asia Subcutaneous Injection market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of Asia Pacific Subcutaneous Injection market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD XX million in 2024.

South America Subcutaneous Injection

According to Cognitive Market Research, the global Subcutaneous Injection market size was estimated at USD XX Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Subcutaneous Injection market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. An expanding pharmaceutical sector and improved healthcare accessibility drive growth in Brazil.
• Argentina's Subcutaneous Injection market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. Rising healthcare expenditures and awareness of self-administration therapies boost Argentina's market.
• Colombia Subcutaneous Injection market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD XX million in 2024.
• Peru Subcutaneous Injection market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD XX million in 2024.
• Chile Subcutaneous Injection market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of Latin America's Subcutaneous Injection market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD XX million in 2024.

Middle East and Africa Subcutaneous Injection

According to Cognitive Market Research, the global Subcutaneous Injection market size was estimated at USD XX Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031..

• The GCC Countries Subcutaneous Injection market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD XX million in 2024. Increased healthcare spending and chronic disease incidence contribute to growth in the GCC region.
• The Egypt Subcutaneous Injection market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD XX million in 2024.
• The South Africa Subcutaneous Injection market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD XX million in 2024. Government initiatives and a focus on chronic disease management propel South Africa's market growth
• The Turkey Subcutaneous Injection market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD XX million in 2024.
• The Nigeria Subcutaneous Injection market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of the MEA Subcutaneous Injection market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD XX million in 2024.

Subcutaneous Injection Market Analysis

Subcutaneous Injection Market Product Type Segment Analysis

According to Cognitive Market Research, The syringes segment holds the largest share in the subcutaneous injection market, favored for their simplicity and versatility. These devices have long been the standard for administering medications, particularly in clinical settings and home care. Their design facilitates accurate dosing and ease of use, making them a popular choice among healthcare professionals and patients alike. The availability of various syringe types, including pre-filled and safety-engineered options, enhances their appeal. As the demand for insulin and biologics rises, syringes continue to play a crucial role in delivering these treatments effectively. Their established presence in the market and adaptability to various drug formulations contribute to their dominant position, ensuring they remain a mainstay in subcutaneous administration.

The injection pens segment is the fastest-growing category in the subcutaneous injection market, reflecting a significant shift towards user-friendly administration methods. These devices provide patients with greater autonomy, allowing for easy self-administration of medications, particularly for chronic conditions like diabetes. The convenience of dial-a-dose functionality and portability appeals to a broad range of users, driving adoption rates. Technological advancements, such as smart pens with dose-tracking capabilities and mobile app integration, further enhance the patient experience. This segment's rapid growth is propelled by increased healthcare awareness and the push for personalized medicine, which emphasizes patient empowerment and adherence. As healthcare trends evolve, injection pens are becoming synonymous with modern, efficient treatment paradigms.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Subcutaneous Injection Industry. Request a Free Sample PDF!

Subcutaneous Injection Market Drug Type Segment Analysis

According to Cognitive Market Research, The subcutaneous injection market is primarily segmented into two drug types: biologics and small molecules. The biologics segment stands out as the largest category, driven by the increasing prevalence of chronic conditions such as diabetes, rheumatoid arthritis, and various cancers. Biologics, which include therapeutic proteins and monoclonal antibodies, require precise delivery methods to achieve optimal efficacy. This segment benefits from advancements in biotechnology and a growing pipeline of novel therapies, reinforcing its dominant position. Healthcare providers increasingly favor biologics due to their targeted mechanisms of action and improved patient outcomes. The expanding adoption of biologic therapies across various therapeutic areas underpins the sustained growth of this segment in the market.

The fastest-growing segment within the subcutaneous injection market is the biologics category, fueled by rapid innovations and a shift toward personalized medicine. The emergence of advanced biologic drugs offers promising treatment options for complex and chronic diseases, encouraging healthcare providers to adopt these therapies. Moreover, patient preferences for self-administration methods enhance the appeal of biologics, as patients seek convenient treatment solutions. Rising awareness and education regarding the benefits of biologic therapies further accelerate market growth. Coupled with supportive regulatory frameworks, the biologics segment is expected to experience significant expansion, reflecting a transformative shift in disease management and patient care practices within the healthcare landscape.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Subcutaneous Injection Application Segment Analysis

Subcutaneous Injection Market Application Segment Analysis

According to Cognitive Market Research, The application segment of the subcutaneous injection market encompasses various therapeutic areas, with diabetes management emerging as the largest segment. The increasing prevalence of diabetes globally drives demand for consistent and reliable treatment options, making subcutaneous injections a preferred choice for insulin delivery. Patients favor these devices for their ease of use and the ability to self-administer medication, promoting better adherence to treatment regimens. Furthermore, the growing awareness of diabetes management strategies and the development of advanced insulin formulations enhance the attractiveness of subcutaneous delivery systems. Healthcare providers increasingly recommend these options, further solidifying the segment's position as a cornerstone in chronic disease management.

The rheumatoid arthritis application segment is the fastest-growing area within the subcutaneous injection market. Rising incidences of this autoimmune condition drive the demand for effective treatment options, fostering innovation in biologic therapies delivered via subcutaneous methods. Patients and healthcare professionals appreciate the convenience of self-administered injections, which improve compliance and empower individuals to manage their health proactively. The introduction of new biologics tailored to rheumatoid arthritis has heightened interest in subcutaneous delivery systems, expanding treatment possibilities. Moreover, increasing patient education initiatives and support programs for individuals with rheumatoid arthritis amplify market growth, positioning this segment at the forefront of therapeutic advancements in the subcutaneous injection landscape.

• Diabetes
• Rheumatoid Arthritis
• Cancer
• Other Chronic Diseases

Subcutaneous Injection End-User Segment Analysis

Subcutaneous Injection Market End-use Segment Analysis

According to Cognitive Market Research, the subcutaneous injection market consists of several end-use segments, including hospitals, home care settings, and specialty clinics. Among these, hospitals represent the largest segment due to their extensive patient population requiring regular treatment for chronic conditions. Hospitals are equipped with comprehensive facilities and medical professionals who administer injections and monitor patient responses closely. The high volume of procedures performed in these settings underscores the demand for subcutaneous injection devices. Furthermore, hospitals are increasingly adopting advanced technologies, enhancing the efficiency of drug delivery systems. This emphasis on patient safety and care quality solidifies hospitals' position as the dominant force within the subcutaneous injection market, attracting significant investments and fostering innovation in device design.

Home care settings are recognized as the fastest-growing segment in the subcutaneous injection market, driven by a paradigm shift toward patient-centered care. The rise in chronic diseases necessitates regular medication administration, prompting patients to seek convenient self-administration options. The proliferation of user-friendly devices, such as injection pens and infusion pumps, empowers patients to manage their health effectively at home. The trend toward home healthcare is supported by technological advancements that facilitate remote monitoring and improve treatment adherence. As patients increasingly prefer the autonomy and comfort of managing their therapies outside traditional healthcare facilities, the home care segment is poised for rapid growth, transforming how chronic conditions are treated and managed.

• Hospitals
• Home Care Settings
• Specialty Clinics

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion